All articles by Vijay Madhukar Singavarapu

  1. Deals this week: Voyager Therapeutics, Pulmatrix, Horizon Discovery

    Voyager Therapeutics will develop and commercialise Neurocrine Biosciences’ gene therapy candidates used to treat severe neurological conditions after a collaboration was…
    Read More…

    1 Feb
  2. Deals this week: PeptiDream, Proteus Digital Health, Novartis

    PeptiDream has entered an agreement with Shionogi for identifying and developing a series of blood-brain barrier (BBB) penetrating peptide drug…
    Read More…

    25 Jan
  3. Deals this week: Ferring Pharmaceuticals, Mirati, Juvenescence

    Ferring Pharmaceuticals (US) has entered an exclusive agreement with Sun Pharmaceutical Industries to acquire the commercialisation rights for a generic…
    Read More…

    18 Jan
  4. M&As this week: Tabula Rasa, Generex, Flex Pharmaceuticals

    Tabula Rasa HealthCare has completed the acquisition of DoseMe. DoseMe’s advanced precision dosing tool DoseMeRx™ and Tabula’s Medication Risk Mitigation (MRM)…
    Read More…

    11 Jan
  5. Deals this week: Keros Therapeutics, Opollomics, CANbridge

    Keros Therapeutics has raised $23m in a series B funding round. Existing investors Pontifax, Arkin Bio Ventures, Partners Innovation Fund, and…
    Read More…

    11 Jan
  6. M&As this week: MabSpace Biosciences, Cambrex, Hetero Labs

    MabSpace Biosciences has merged with HJB to create a fully-integrated biotherapeutics company named Transcenta Holding. Transcenta will have more than…
    Read More…

    4 Jan
  7. Deals this week: Antengene Corporation, Acer Therapeutics, Menarini

    Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital and FountainVest. The funding round…
    Read More…

    4 Jan
  8. Deals this week: DelSiTech, Marken, Erasca

    DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics. Innovare will make upfront…
    Read More…

    21 Dec
  9. M&As this week: 10x Genomics, Atlantic Research Group, AGC

    10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain…
    Read More…

    14 Dec
  10. Deals this week: Moderna, Oxford Biotherapeutics, CBT Pharmaceuticals

    Moderna has priced its initial public offering (IPO) of 26 million common stock shares at $23 a share, with the aim…
    Read More…

    14 Dec

Go Top